Seaview Investment Managers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Seaview Investment Managers's BMY Position: Q1 2021 in Review
Seaview Investment Managers sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 57,180 shares — an estimated $3.55M sold.
Seaview Investment Managers first reported a position in BMY in Q3 2020 and held it in 2 quarters. The position peaked at $3.55M in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Seaview Investment Managers reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
- Seaview Investment Managers sold 57,180 Bristol-Myers Squibb shares in Q1 2021, an estimated $3.55M.
- Seaview Investment Managers first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 2 quarters.
- Seaview Investment Managers's Bristol-Myers Squibb position peaked at $3.55M in Q4 2020.
- 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Seaview Investment Managers's 13F filing for Q1 2021, filed 7 May 2021.